ECOGENETICS OF PANCREATIC CANCER: A NATIONAL REGISTRY OF FAMILIES

胰腺癌的生态遗传学:国家家族登记

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long-term objective, of which this proposed work is a beginning, is to identify the ecogenetic (gene-environment) origins of a devastating, frequent malignant neoplasm, namely adenocarcinoma of the exocrine pancreas. The plan of attack hinges on the proven strategy of interdisciplinary studies of families that appear to have an excess of cancer, in this case, cancer of the pancreas. The major null hypothesis is that pancreatic cancer, as it occurs in families, has no distinguishing features from the presumedly more frequent sporadic type. The alternative hypothesis is that, when well-documented and analyzed in the aggregate, a large group of nuclear families ascertained through the occurence of pancreatic cancer in just two relatives will show some distinctive demographic or laboratory feature from what is known about sporadic (non-familial) pancreatic cancer; and, further, that even pilot work with interdisciplinary collaborators in tumor marker biology, cytogenetics, molecular oncology, etc., will yield specific testable hypotheses that can be addressed in follow-up investigations. Specific Aim 1 - To update familial aggregations of adenocarcinoma of the exocrine pancreas, 32 of which were identified by the principal investigator at the National Cancer Institute and at the University of Pittsburgh, and to expand at the University of Oklahoma, a national registry of pancreatic cancer families, and to accrue additional families on an ongoing basis to a total of 150. Specific Aim 2 - On registered families, to acquire relevant etiologic information and biological specimens (fresh, frozen, and fixed malignant and normal tissue, lymphocytes, DNA, and sera) and to maintain a specium repository. Specific Aim 3 - To conduct preliminary assays on the registry material, including specimens from patients and from first-degree relatives (who are possibly at high risk of cancer of the exocrine pancreas). In short, we will continue and expand a national research resource of interdisciplinary studies of pancreatic cancer and to catalyze preliminary translational research. Akin to the much larger, NCI's Cooperative Family Registries for Breast and Colorectal Cancer Studies, the Familial Pancreatic Cancer Registry would, pari passu, identify a population at increased risk for pancreatic cancer that may be useful for studies of early detection, prevention, and innovative therapies.
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。这项拟议的工作是一个开始,其长期目标是确定一种毁灭性的、频繁的恶性肿瘤,即外分泌腺癌的生态(基因-环境)起源。攻击计划取决于对似乎有过多癌症的家庭进行跨学科研究的成熟策略,在这种情况下,癌症是胰腺癌。主要的无效假设是胰腺癌,因为它发生在家族中,没有区别于推测更常见的散发性类型的特征。另一种假设是,当很好地记录和分析时,通过仅在两个亲属中发生胰腺癌而确定的一大群核心家族将显示出与已知的散发性(非家族性)胰腺癌不同的一些独特的人口学或实验室特征;此外,即使是与肿瘤标记物生物学、细胞遗传学、分子肿瘤学等跨学科合作者的试点工作,也将产生具体的可检验的假说,可以在后续研究中解决。具体目标1--更新胰腺外分泌腺癌的家族聚集性,其中32个家族聚集性是由国家癌症研究所和匹兹堡大学的首席研究员确定的,并在俄克拉荷马大学扩大,这是一个全国性的胰腺癌家族登记机构,并不断增加新的家族,总数达到150个。具体目标2--关于登记的家庭,获取相关的病原学信息和生物标本(新鲜、冷冻和固定的恶性和正常组织、淋巴细胞、DNA和血清),并维持一个专门的储存库。具体目标3--对登记材料进行初步分析,包括病人和一级亲属(他们可能有患胰腺外分泌癌的高风险)的标本。简而言之,我们将继续并扩大胰腺癌跨学科研究的全国性研究资源,并催化初步的翻译研究。与规模更大的NCI乳腺癌和结直肠癌研究合作家庭登记处类似,家族性胰腺癌登记处将识别出胰腺癌风险较高的人群,这可能有助于早期发现、预防和创新治疗的研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John J. Mulvihill其他文献

Genetic linkage studies with neurofibromatosis: the question of heterogeneity.
与神经纤维瘤病的遗传连锁研究:异质性问题。
  • DOI:
  • 发表时间:
    1987
  • 期刊:
  • 影响因子:
    4
  • 作者:
    M. Spence;Robert S. Sparkes;Dilys M. Parry;Sherri J. Bale;Victoria K. Cortessis;John J. Mulvihill
  • 通讯作者:
    John J. Mulvihill
Sister chromatid exchange and chromosome fragility in the nevoid basal cell carcinoma syndrome.
痣基底细胞癌综合征中的姐妹染色单体交换和染色体脆性。
  • DOI:
    10.1016/0165-4608(89)90095-2
  • 发表时间:
    1989
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Allen E. Bale;Sherri J. Bale;Hemalatha Murli;James L. Ivett;John J. Mulvihill;Dilys M. Parry
  • 通讯作者:
    Dilys M. Parry
Noise Pollution: Neonatal Aspects
噪音污染:新生儿方面
  • DOI:
    10.1542/peds.54.4.476
  • 发表时间:
    1974
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Robert W. Miller;W. Brendel;R. Brent;J. Chisolm;John L. Doyle;A. Ebbin;E. L. Fagan;L. Finberg;D. Méndez;John J. Mulvihill;S. Falk;J. W. Flynt;C. Frantz;J. Knelson;Sarah H. Knutti
  • 通讯作者:
    Sarah H. Knutti
Familial eosinophilia: clinical and laboratory results on a U.S. kindred.
家族性嗜酸性粒细胞增多症:美国亲属的临床和实验室结果。
  • DOI:
  • 发表时间:
    1998
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. Lin;T. B. Nutman;D. Kaslow;John J. Mulvihill;Laura Fontaine;Beverly J. White;Turid Knutsen;Karl S. Theil;P. Raghuprasad;Alisa M. Goldstein;Margaret A. Tucker
  • 通讯作者:
    Margaret A. Tucker
Cryptic and complex chromosomal rearrangements and the deletion of <em>TP53</em> gene in a patient with leukemic mantle cell lymphoma
  • DOI:
    10.1016/j.cancergencyto.2006.04.002
  • 发表时间:
    2006-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lijun Zhang;Williams F. Kern;Zongxing Yu;John J. Mulvihill;Shibo Li
  • 通讯作者:
    Shibo Li

John J. Mulvihill的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John J. Mulvihill', 18)}}的其他基金

ECOGENETICS OF PANCREATIC CANCER: A NATIONAL REGISTRY OF FAMILIES
胰腺癌的生态遗传学:国家家族登记
  • 批准号:
    7608087
  • 财政年份:
    2007
  • 资助金额:
    $ 0.05万
  • 项目类别:
Oklahoma Planning Grant for Clinical /Translational Scie
俄克拉荷马州临床/转化科学规划拨款
  • 批准号:
    7216101
  • 财政年份:
    2006
  • 资助金额:
    $ 0.05万
  • 项目类别:
OKLAHOMA PLANNING GRANT FOR CLINICAL AND TRANSLATIONAL SCIENCE AWARD
俄克拉荷马州临床和转化科学规划拨款奖
  • 批准号:
    7682671
  • 财政年份:
    2006
  • 资助金额:
    $ 0.05万
  • 项目类别:
CANCER AND MORTALITY IN NEUROFIBROMATOSIS BY GENOTYPE
按基因型划分的神经纤维瘤病的癌症和死亡率
  • 批准号:
    7378097
  • 财政年份:
    2006
  • 资助金额:
    $ 0.05万
  • 项目类别:
ECOGENETICS OF PANCREATIC CANCER: A NATIONAL REGISTRY OF FAMILIES
胰腺癌的生态遗传学:国家家族登记
  • 批准号:
    7203326
  • 财政年份:
    2005
  • 资助金额:
    $ 0.05万
  • 项目类别:
NEUROFIBROMATIOSIS (NF1) GENE TESTING
神经纤维瘤病 (NF1) 基因检测
  • 批准号:
    7203327
  • 财政年份:
    2005
  • 资助金额:
    $ 0.05万
  • 项目类别:
Ecogenetics of Pancreatic Cancer: A National Registry of Families
胰腺癌的生态遗传学:国家家庭登记处
  • 批准号:
    6981265
  • 财政年份:
    2004
  • 资助金额:
    $ 0.05万
  • 项目类别:
Neurofibromatosis (NF1) Gene Testing
神经纤维瘤病 (NF1) 基因检测
  • 批准号:
    6981266
  • 财政年份:
    2004
  • 资助金额:
    $ 0.05万
  • 项目类别:
UICC Intl Conference on Familial Cancer--US Support
UICC 国际家族癌症会议——美国支持
  • 批准号:
    6602210
  • 财政年份:
    2003
  • 资助金额:
    $ 0.05万
  • 项目类别:
Fas neuroldev disorders with children & OR adolescents
儿童 Fas 神经老化障碍
  • 批准号:
    7184775
  • 财政年份:
    2001
  • 资助金额:
    $ 0.05万
  • 项目类别:

相似海外基金

Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
  • 批准号:
    23K26797
  • 财政年份:
    2024
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Proton radiation therapy combined with immunotherapy for enhancing antitumor immune responses in pancreatic cancer murine models.
质子放射治疗与免疫治疗相结合,增强胰腺癌小鼠模型的抗肿瘤免疫反应。
  • 批准号:
    24K10423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Conditionally Activable Small Molecule Pro-Drug Conjugate for Targeted Treatment of Pancreatic Cancer
用于胰腺癌靶向治疗的条件激活小分子前药偶联物
  • 批准号:
    EP/Y036336/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Research Grant
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
  • 批准号:
    10751872
  • 财政年份:
    2024
  • 资助金额:
    $ 0.05万
  • 项目类别:
Developing a Curative Therapy for Cancer Stroma Alterations in Pancreatic Cancer and Other Intractable Solid Tumors
开发针对胰腺癌和其他难治性实体瘤的癌症基质改变的治疗方法
  • 批准号:
    23H02868
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional Analysis of Girdin in Anticancer Drug-Resistant Pancreatic Cancer and Its Application to Novel Therapeutic Agents
Girdin在抗癌药物耐药性胰腺癌中的功能分析及其在新型治疗药物中的应用
  • 批准号:
    23K08138
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Photoimmunotherapy for Novel Targets in Peritoneal metastasis of Pancreatic Cancer
光免疫疗法治疗胰腺癌腹膜转移的新靶点
  • 批准号:
    23K06753
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring the molecular function of HIKESHI in pancreatic cancer tumor development and response to thermal/chemotherapy.
探索 HIKESHI 在胰腺癌肿瘤发展和热/化疗反应中的分子功能。
  • 批准号:
    23K14610
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
New stool biomarker proteins for pancreatic cancer by the proteome analysis
通过蛋白质组分析发现胰腺癌的新粪便生物标志物蛋白
  • 批准号:
    23K14643
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Nanobubbles for earlier pancreatic cancer detection
用于早期胰腺癌检测的纳米气泡
  • 批准号:
    2886053
  • 财政年份:
    2023
  • 资助金额:
    $ 0.05万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了